We are live on ! Find out more
SC

Savant Capital Portfolio holdings

AUM $20.7B
1-Year Est. Return 19.76%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+19.76%
3 Year Est. Return
+51.75%
5 Year Est. Return
+48.44%
10 Year Est. Return
+194.21%
AUM
$17.6B
AUM Growth
+$1.1B
Cap. Flow
+$718M
Cap. Flow %
4.08%
Top 10 Hldgs %
43.97%
Holding
1,439
New
128
Increased
690
Reduced
503
Closed
77

Sector Composition

Rank Sector Weight
1 Technology 3.86%
2 Financials 2.08%
3 Healthcare 1.54%
4 Industrials 1.45%
5 Consumer Discretionary 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
1001
Texas Pacific Land
TPL
$27.8B
$333K ﹤0.01%
1,160
-67
-5% -$20.5K
SCHH icon
1002
Schwab US REIT ETF
SCHH
$11.5B
$333K ﹤0.01%
15,946
-1,359
-8% -$28.8K
BBCA icon
1003
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
$333K ﹤0.01%
3,580
+528
+17% +$47K
QSR icon
1004
Restaurant Brands International
QSR
$25.7B
$333K ﹤0.01%
+4,874
New +$336K
JMTG
1005
JPMorgan Mortgage-Backed Securities ETF
JMTG
$6.69B
$333K ﹤0.01%
6,513
-828
-11% -$42.4K
DAR icon
1006
Darling Ingredients
DAR
$9.64B
$332K ﹤0.01%
9,236
+2,046
+28% +$69.3K
LULU icon
1007
lululemon athletica
LULU
$13.5B
$331K ﹤0.01%
+1,591
New +$288K
PBF icon
1008
PBF Energy
PBF
$8.57B
$329K ﹤0.01%
12,145
+111
+0.9% +$3.56K
MDB icon
1009
MongoDB
MDB
$27.1B
$329K ﹤0.01%
784
-47
-6% -$17.1K
AL
1010
DELISTED
Air Lease Corp
AL
$328K ﹤0.01%
5,105
+820
+19% +$52.4K
IHI icon
1011
iShares US Medical Devices ETF
IHI
$3.13B
$327K ﹤0.01%
5,268
-160
-3% -$9.88K
TAK icon
1012
Takeda Pharmaceutical
TAK
$54.6B
$327K ﹤0.01%
20,980
-1,227
-6% -$17.5K
CAMT icon
1013
Camtek
CAMT
$6.18B
$326K ﹤0.01%
3,070
+772
+34% +$86.7K
HUBB icon
1014
Hubbell
HUBB
$25B
$326K ﹤0.01%
733
+142
+24% +$62.2K
AAXJ icon
1015
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.68B
$325K ﹤0.01%
3,489
-3,288
-49% -$306K
AR icon
1016
Antero Resources
AR
$11.1B
$325K ﹤0.01%
9,426
+1,224
+15% +$41.5K
XCNY
1017
State Street SPDR S&P Emerging Markets ex-China ETF
XCNY
$9.68M
$324K ﹤0.01%
11,540
-727
-6% -$20.3K
VCR icon
1018
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$324K ﹤0.01%
822
VRSK icon
1019
Verisk Analytics
VRSK
$25.4B
$323K ﹤0.01%
1,445
-218
-13% -$49.2K
KKR icon
1020
KKR & Co
KKR
$91.1B
$323K ﹤0.01%
2,534
+276
+12% +$34.3K
KB icon
1021
KB Financial Group
KB
$41.4B
$322K ﹤0.01%
3,741
+885
+31% +$74.6K
DXPE icon
1022
DXP Enterprises
DXPE
$2.43B
$321K ﹤0.01%
2,921
+9
+0.3% +$980
HIMU
1023
iShares High Yield Muni Active ETF
HIMU
$2.38B
$320K ﹤0.01%
6,581
+274
+4% +$13.4K
PDD icon
1024
Pinduoduo
PDD
$126B
$319K ﹤0.01%
2,816
+187
+7% +$23.2K
ASB icon
1025
Associated Banc-Corp
ASB
$5.83B
$319K ﹤0.01%
12,396
+1,316
+12% +$33.9K

Similar funds

Savant Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Savant Capital held 1,439 positions worth $17.6B, up 6.7% from $16.5B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Savant Capital deployed $718M of net new capital in Q4 2025, opening 128 new positions and adding to 690 existing holdings. Its largest new stake was Vanguard S&P Small-Cap 600 Value ETF: 246,738 shares worth $24.1M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $72.1M trimmed.

  • Savant Capital's largest Q4 2025 buy was Vanguard S&P Small-Cap 600 Value ETF: 246,738 shares worth $24.1M.
  • Savant Capital added most to Vanguard Total International Bond ETF in Q4 2025, an estimated $95.4M increase.
  • Savant Capital's biggest Q4 2025 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $72.1M.
  • Savant Capital fully exited iShares MSCI ACWI ex US ETF in Q4 2025, selling an estimated $3.6M.
  • Savant Capital's ten largest holdings make up 44% of its $17.6B portfolio in Q4 2025.
  • Savant Capital opened 128 new positions and closed 77 in Q4 2025.
  • Savant Capital's portfolio value rose 6.7% quarter-over-quarter to $17.6B.

Based on Savant Capital's 13F filing for Q4 2025, filed 10 Feb 2026.